Hikal logo

Hikal PE ratio, market cap and valuation

NSE: HIKALBSE: 524735Pharmaceuticals & BiotechnologySmall Cap

Last close ₹193.65down ₹9.53 (4.69%)BSE ₹194.75

Share price at the NSE close on 23 Oct 2026. Previous close ₹203.18.

52-week range of traded prices to 23 Oct 2026
₹146.25Low, 30 Mar 2026₹261.00High, 4 Dec 2025
Market cap
₹2,388 Cr1,090th largest listed
P/E
Lossover the last 12 months
P/B
2.0
Dividend yield
0.31%
ROE
−2.7%
ROE without one-offs
3.4%
ROCE
3.5%
Debt to equity
0.57
Volume, NSE
4,03,34641.0% delivered

Hikal PE ratio and valuation against its own history

Each ratio on 23 Oct 2026 beside its median over each window. The ratios are on standalone accounts to Mar 2020 and consolidated from Mar 2021. The PE ratio is the market cap over the profit of the last twelve months.

  • Price to earningsLoss, last twelve months
  • Price to book1.99today

    1 year

    Median 2.20

    Today is at or above 25% of the 247 days

    3 years

    Median 3.06

    Today is at or above 8% of the 744 days

    5 years

    Median 3.35

    Today is at or above 5% of the 1,240 days

    10 years, since Nov 2018

    Median 3.03

    Today is at or above 11% of the 1,974 days

  • Price to sales1.38today

    1 year

    Median 1.52

    Today is at or above 22% of the 247 days

    3 years

    Median 1.91

    Today is at or above 7% of the 744 days

    5 years

    Median 1.96

    Today is at or above 4% of the 1,240 days

    10 years

    Median 1.73

    Today is at or above 23% of the 2,480 days

  • EV to EBITDA13.15today

    1 year

    Median 14.12

    Today is at or above 27% of the 247 days

    3 years

    Median 15.93

    Today is at or above 12% of the 744 days

    5 years

    Median 16.28

    Today is at or above 12% of the 1,240 days

    10 years, since Nov 2018

    Median 14.86

    Today is at or above 38% of the 1,974 days

  • Dividend yield0.31%today

    1 year

    Median 0.52%

    Today is at or above 14% of the 247 days

    3 years

    Median 0.40%

    Today is at or above 15% of the 744 days

    5 years

    Median 0.41%

    Today is at or above 10% of the 1,240 days

    10 years

    Median 0.51%

    Today is at or above 8% of the 2,480 days

  • Earnings yield−1.42%today

    1 year

    Median −0.58%

    Today is at or above 20% of the 247 days

    3 years

    Median 1.60%

    Today is at or above 7% of the 744 days

    5 years

    Median 1.94%

    Today is at or above 4% of the 1,240 days

    10 years

    Median 3.15%

    Today is at or above 2% of the 2,480 days

Each track ranks every trading day in the window from the day the ratio was lowest to the day it was highest; the dot is today. The share under it is how many of those days the ratio was at or below today's level, so a high share means today is higher than on most days in the window. A window is shown only when the ratio is held on most of its trading days; a day after a loss-making year has no P/E. Dividend yield is in per cent. When a year's dividend goes ex later than the year before's, the yield reads zero for the days between; a run of under 60 such trading days is left out of the yield's medians and percentiles. The ex-date is the day from which a buyer of the share no longer gets the dividend.

How each ratio is worked out, with today's figures

The twelve months: Filed 6 AugThe balance sheet: Filed 27 May

  • Price to book =Market cap÷Net worth₹1,199 Cr
  • Price to sales =Market cap÷Revenue, last twelve months₹1,735 Cr
  • Enterprise value =Market cap+Borrowings₹681 Cr−Cash₹14 Cr
  • EV to EBITDA =Enterprise value÷Operating profit, last twelve months₹232 Cr
  • Market cap =Close×Shares in issue12,33,00,748at 30 Sep 2026
Net profit, last twelve months
−₹34 Cr

Consolidated accounts, the twelve months to Jun 2026, balance sheet at Mar 2026, ₹ crore.Hikal financials ›

Hikal valuation at each year end

On the last trading day of each March, the month the company's year ends.Hikal dividend history

RatioMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Market cap (₹ crore)9651,7571,6912,1418591,7704,9603,4733,2684,9251,814
Price to earnings33.028.521.322.59.216.626.055.045.666.0Loss
Price to bookNo balance sheetNo balance sheetNo balance sheet3.01.12.14.93.22.94.11.5
Price to sales1.11.81.41.40.51.12.51.81.82.71.0
EV to EBITDANo balance sheetNo balance sheetNo balance sheet9.55.08.214.218.415.418.910.4
Dividend yield0.85%0.75%0.63%0.63%2.30%0.84%0.55%0.36%0.45%0.30%0.68%
Earnings yield3.0%3.5%4.7%4.4%10.9%6.0%3.8%1.8%2.2%1.5%−0.7%
A ratio that does not exist on the day says why in its cell. The ratios are on standalone accounts to Mar 2020 and consolidated from Mar 2021.

Hikal market cap, ten years

The last trading day of each month.

Market cap, ₹ crore

  • Market cap

Earnings per share, book value and enterprise value

From the close on 23 Oct 2026, with the last twelve months' results.

Enterprise value
₹3,055 Cr
Earnings per share
−₹2.74
Book value per share
₹97.23
Dividends, last 12 months
₹0.60
Public's market cap
₹744 Cr

Against Pharmaceuticals

216 listed companies in Pharmaceuticals, each priced on its last trading day; Hikal is 71st among them by market cap. Each median leaves out Hikal itself and takes the other companies that have the figure.

Industry median P/E
28.2Across 156 other companies
Industry median P/B
2.9Across 186 other companies
Industry median EV/EBITDA
18.7Across 141 other companies
Industry median dividend yield
0.53%Across 88 other companies